| |
|
|
|
Clearside Biomedical Inc.  
|
|
1.58 0.03 (0.02%) |
02-15 16:00 |
|
Open: |
1.62 |
Pre close: |
1.55 |
Target:
|
2.02 
|
|
High: |
1.73 |
Low: |
1.57 |
Resistance:
|
1.73
2.02
|
|
Volume: |
3,529,015 |
Market Cap: |
51M |
Support:
|
1.33
1.09
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.47
|
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
1.26 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
2.67  |
Stochastic Oscillator |
%K(14,3):
|
84.92 |
|
MA(250): |
6.96 |
%D(3): |
83.75 |
|
Average Volume(K) |
3-Month: |
69984
|
52-Week |
High:
|
15.33 |
|
10-Days: |
175935 |
Low: |
0.99 |
|
RSI |
RSI(14):
|
70.07 |
Change(%): |
-75.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.670 |
Return on Equity (ttm) |
-192.7 |
Shares Out. (M) |
32.02 |
|
EPS Est. Current Year |
-2.100 |
Return on Assets (ttm) |
-125.6 |
Shares Float (M) |
31.38 |
|
EPS Est. Next Year |
-2.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.590 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
71.60 |
|
Forward EPS |
-2.080 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.890 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.59 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.78 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-70.03 |
P/S |
0.00 |
|
Operating Margin |
-141152.73 |
Levered Free Cash Flow
(M) |
-41.03 |
P/CF |
-0.72 |
|
|
|
|
|
|
